ABBV ready for shortABBV seems ready for short, RSI already broken trend line.
Details are on chart.
4,402.68
0.01 BRL
24.08 B BRL
271.31 B BRL
About AbbVie Inc.
Sector
CEO
Robert A. Michael
Headquarters
North Chicago
Website
Founded
2011
ISIN
BRABBVBDR001
FIGI
BBG00CRJ2Y32
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ABBV34 is featured.
